抄録
Flow diverters (FDs) have recently been developed as innovative endovascular devices to treat unruptured intracranial aneurysms. FDs can alter and reduce the blood flow into the aneurysmal sac and subsequently induce progressive aneurysmal thrombosis while preserving the patency of the surrounding small vessels and perforators. Therefore FD therapy is superior to conventional endosaccular coil embolization with its high complete occlusion rate and low risk of recurrence. Because there are risks of morbidity and neurological mortality, appropriate case selection and procedures performed by skillful physicians are mandatory for the effective use of FDs.
